Clinical Trial Update: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial ENLIGHTED is evaluating endoluminal light-activated treatment for upper tract urothelial carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• Endoluminal LIGHT Activated Treatment

Snippet

Sponsor: Steba Biotech S.A. | Conditions: Transitional Cell Cancer of Renal Pelvis and Ureter | Phase 3 | Status: RECRUITING